Old Web
English
Sign In
Acemap
>
Paper
>
FDA-Approved Excipient N,N-Dimethylacetamide Attenuates Inflammatory Bowel Disease in In-Vitro and In-Vivo Models
FDA-Approved Excipient N,N-Dimethylacetamide Attenuates Inflammatory Bowel Disease in In-Vitro and In-Vivo Models
2021
Jagadish Koya
Tong Shen
Geming Lu
Alex G. Gauthier
Lin L. Mantell
Charles R. Ashby
Sandra E. Reznik
Keywords:
Excipient
In vivo
Pharmacology
Dimethylacetamide
In vitro
Medicine
Inflammatory bowel disease
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]